Financial results - PHARMATALENT EUROPE INC. S.R.L.

0.00
Financial Summary - Pharmatalent Europe Inc. S.r.l.
Unique identification code: 44256478
Registration number: J40/8379/2021
Nace: 6202
Sales - Ron
1.306.112
Net Profit - Ron
111.567
Employee
4
Open Account
The most important financial indicators for the company Pharmatalent Europe Inc. S.r.l. - Unique Identification Number 44256478: sales in 2023 was 1.306.112 euro, registering a net profit of 111.567 euro and having an average number of 4 employees. Firma isi desfasoara activitatea in domeniul Activitati de consultanta in tehnologia informatiei having the NACE code 6202.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Pharmatalent Europe Inc. S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - - - - - - 322.784 730.161 1.306.112
Total Income - EUR - - - - - - - 323.941 757.951 1.324.418
Total Expenses - EUR - - - - - - - 52.501 352.099 1.204.288
Gross Profit/Loss - EUR - - - - - - - 271.440 405.852 120.130
Net Profit/Loss - EUR - - - - - - - 267.151 400.455 111.567
Employees - - - - - - - 1 3 4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 79.4%, from 730.161 euro in the year 2022, to 1.306.112 euro in 2023. The Net Profit decreased by -287.673 euro, from 400.455 euro in 2022, to 111.567 in the last year.
See Company Data

Check the financial reports for the company - Pharmatalent Europe Inc. S.r.l.

Rating financiar

Rating financiar -
Pharmatalent Europe Inc. S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Pharmatalent Europe Inc. S.r.l. - CUI 44256478

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 15.632 26.006 2.833 - - - - - - -
Current Assets - - - - - - - 272.415 436.444 609.845
Inventories - - - - - - - 0 0 0
Receivables - - - - - - - 25.967 142.831 303.557
Cash - - - - - - - 246.448 293.613 306.288
Shareholders Funds - - - - - - - 268.145 457.049 567.230
Social Capital - - - - - - - 995 998 995
Debts - - - - - - - 7.102 3.957 49.226
Income in Advance - - - - - - - 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "6202 - 6202"
CAEN Financial Year 6202
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 609.845 euro in 2023 which includes Inventories of 0 euro, Receivables of 303.557 euro and cash availability of 306.288 euro.
The company's Equity was valued at 567.230 euro, while total Liabilities amounted to 49.226 euro. Equity increased by 111.567 euro, from 457.049 euro in 2022, to 567.230 in 2023.
Monitors the Company

Activate a subscription with unlimited access and get contact details for any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Recurring - monthly payment

Pay

25,21 EUR / month
NELIMITAT

Reports that can be accessed based on the subscription:

  • ✔ Financial Rating
  • ✔ Payment Limits
  • ✔ Outstanding Debts
  • ✔ Probability of Insolvency
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
See Subscriptions

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.